Inicio > Medicina Interna > Utilidad de un nivel elevado de procalcitonina sérica como marcador temprano de bacteriemia en pacientes neutropénicos con fiebre postquimioterapia > Página 6

Utilidad de un nivel elevado de procalcitonina sérica como marcador temprano de bacteriemia en pacientes neutropénicos con fiebre postquimioterapia

BIBLIOGRAFÍA

1.- Jiunn- yih wu, Si- huei lee, Chin-jung shen y cols. Use of serum procalcitonin to detect bacterial infection in patients with autoinmune diseases. Arthritis and reumatism. 2012; 9: 3034-3042

2.-Vasiliki P. Theodorou, Vasilios e Papaioannou, Gregory a Tripsianis y cols. Procalcitonina and procalcitonina kinetics for diagnosis and prognosis of intravascular catheter related bloodstream infections in selected critically ill patients: a prospective obsevational study. Bmc infectious diseases 2012, 12:247

3.-Sakr C. Sponholz, F. Tuchen y cols. The role of procalcitonin in febrile neutropenic patients: review of literature. Infection 2008; 36: 396-407

4.-Xiu-lan lu, Zheng-hui xiao, Mei-yu yang y cols. Diagnostic value if serum procalcitonin in patients with chronic renal insufficiency: a sistematic review and meta-analysis. Nephrol dial transplant (2013) 28: 122-129.

5.- Anna Prkno, Christina Wacker, Frank M. Brunkhorst and cols. Procalcitonin-guided therapy in intensive care unit patiients with severe sepsis and septic shock -a systematic review ando meta-analysis. Critical care 2013, 17: r291

6.- Moshen meidani, Farzin khorvash, Hojat Abolghasemi y cols. Procalcitonin and quantitative c-reactive protein role in the early diagnosis of sepsis in patients with febrile neutropenia. South asian journal of cancer. 2013; 2: 216-219.

7.- Kallio H. Sourcel a. Bloigu y cols. C- reactive protein, procalcitonin and interleukin-8 in the primary diagnosis of infectious in cancer patients. European journal of cancer. 2000; 36: 889-894.

8.- Irwin AD, Carrol ED: Procalcitonin. Archs Dis Child Educ Pract Ed 2011, 96(6):228-233

9.- Shi-Kun Yang, Li Xiao, Hao Zhang y cols. Significance of serum procalcitonin as biomarker for detection of bacterial peritonitis: a systematic review and meta-analysis. 2014; 14:452

10.- Juan Manuel Gomez-Cerquera, Rafael Daroca-Perez, Ramon Beza-Trinidad y cols. Validity of procalcitonin for the diagnosis of bacterial infection in elderly patients. Enferm infecc microbiol clin. 2014; 1241

11.- Mizuiki Aimoto, Hideo Koh, Takako katayama y cols. Diagnostic performance of serum high- sensitivity procalcitonin and serum c-reactive protein tests for detecting bacterial infection in febrile neutropenia. Infection 2014, 42: 971-979

12.- J. De naurouis, i. Novitzky-basso, m.j. Gill y cols.mangament of febrile neutropenia: ESMO clinical practice guidelines. Annals of oncology; 2010:252-256

13.- Isidro Jarque, Miguel Salavert y Miguel a. Sanz. Manejo del paciente neutropenico con fiebre. Enferm infecc microbiol clin. 2005; 24-29.

14.- Ordonez Ca, Puyana JC:Management of peritonitis in the critically ill patient. surg Clin North Am 2006, 86(6):1323-1349

15.-Christofilopoulou S, Charvalos E, Petrikkos G. Could procalcitonin be a predictive biological marker in systematic fungal infections?.Eur J Intern Med 2002;13:439-5.

16.- Limper M, deKruif MD, Duits AJ y Cols.The diagnostic role of procalcitonin and other biomarkers in discriminatins infectious from no infectiuos fever. J infect 2010;60:409-16

17.- Giamarellou H, Giamarellos-Bourboulis EJ, Repoussis P. y cols. Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia: Experience from a multicentre study. Clin Microbiol Infect 2004;10:628-33